The companies, which are already partners in a CRM joint venture in the People’s Republic, originally announced the deal last November.
London-based LivaNova said that its announcement follows “successful completion of works council information and consultation requirements in France,” and that it expects the deal to close during the second quarter of 2018.
LivaNova, formed by the $2.7 billion merger of Italy’s Sorin and Cyberonics in October 2015, said last September that it was putting the CRM business on the auction block. The business, which currently employs 900 individuals, pulled in sales of $249 million in 2016.
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.